Home/Filings/4/0001169245-22-000064
4//SEC Filing

Hutson Nancy J 4

Accession 0001169245-22-000064

CIK 0001169245other

Filed

May 19, 8:00 PM ET

Accepted

May 20, 4:45 PM ET

Size

8.0 KB

Accession

0001169245-22-000064

Insider Transaction Report

Form 4
Period: 2022-05-19
Transactions
  • Award

    Non-employee Director Stock Option (right to buy)

    2022-05-19+17,50017,500 total
    Exercise: $0.84Exp: 2032-05-18Common Stock (17,500 underlying)
  • Award

    Restricted Stock Units

    2022-05-19+3,7503,750 total
    Common Stock (3,750 underlying)
Footnotes (3)
  • [F1]The shares subject to the option shall vest on the earlier of the one-year anniversary of the grant date or the 2023 annual stockholder meeting, subject to the Reporting Person's continuous service through such date.
  • [F2]Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of PhaseBio Pharmaceuticals, Inc. common stock.
  • [F3]The RSUs shall vest and be delivered to the Reporting Person on the earlier of the one-year anniversary of the grant date or the 2023 annual stockholder meeting, subject to the Reporting Person's continuous service through such date.

Issuer

PhaseBio Pharmaceuticals Inc

CIK 0001169245

Entity typeother

Related Parties

1
  • filerCIK 0001379222

Filing Metadata

Form type
4
Filed
May 19, 8:00 PM ET
Accepted
May 20, 4:45 PM ET
Size
8.0 KB